TNGX today
$25.73+$1.43 (+5.88%)close Nov 11, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bullish
1 hourStrong Bullish
15 minBearish
5 minSymmetric Triangle
Daily trend turns down below $19.34
Key levels
Resistance$30.25
Resistance$27.98
Support$24.75
Support$20.74
Latest news & SEC filings
AnalystAnalysts adjust their views on Tango Therapeutics
AnalystJP Morgan keeps Overweight on Tango Therapeutics, lifts target to $47
AnalystWedbush keeps Outperform rating on Tango Therapeutics, cuts price target to $40
All TNGX news →About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company developing targeted cancer medicines. It focuses on small molecules designed to act selectively in tumor cells carrying specific genetic alterations, using biomarker-based patient selection. Its lead programs are PRMT5 inhibitors, including vopimetostat for non-CNS cancers and TNG456 for brain tumors such as glioblastoma, along with earlier-stage programs targeting other precision oncology pathways. The company operates in the United States.
Based on the company's 10-K filed Mar 5, 2026.
Nasdaq · Healthcare
Tango Therapeutics, Inc. (TNGX)
What Is the Price Target for TNGX?
SEPT Low Target
$24.00
SEPT Mid Target
$43.00
SEPT High Target
$68.00
Analyst Consensus
$43.00
Is TNGX a Buy or Sell Right Now?
Thesis
- •Revenue growing 48.3% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for TNGX.
Start Free Trial →Is TNGX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$36.67
25
Moat Score
NONE
4/9
Piotroski Score
28.3
Altman Z-Score
What Is Smart Money Doing with TNGX?
Insider Signal
SELLING
0 buys / 11 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Crystal Adam | officer | Buy | 5,000 | $15K | Nov 2, 2026 |
| Crystal Adam | officer | Sale | 3,900 | $87K | Nov 2, 2026 |
| Crystal Adam | officer | Sale | 1,100 | $25K | Nov 2, 2026 |
| Newcomb Jessica | officer | Sale | 5,571 | $124K | Nov 2, 2026 |
| Newcomb Jessica | officer | Sale | 1,460 | $34K | Nov 2, 2026 |
| Crystal Adam | officer | Buy | 27,000 | $140K | Oct 1, 2026 |
| Crystal Adam | officer | Sale | 26,400 | $646K | Oct 1, 2026 |
| Crystal Adam | officer | Sale | 600 | $15K | Oct 1, 2026 |
| Newcomb Jessica | officer | Sale | 700 | $16K | Sep 22, 2026 |
| Newcomb Jessica | officer | Sale | 5,100 | $122K | Sep 22, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →TNGX Growth Story
Revenue YoY
48.3%
3yr Revenue CAGR
35.9%
EPS Growth YoY
26.89%
FCF Growth YoY
-5.8%
Revenue Trend
STRONG
Dark Pool Trades for TNGX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for TNGX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 24:43:17 | $25.73 | 1,000 | $$26K | BUY |
| 21:57:11 | $25.73 | 1,100 | $$28K | BUY |
| 21:00:38 | $26.00 | 10,000 | $$260K | BUY |
| 21:00:04 | $25.73 | 6,093 | $$157K | SELL |
| 21:00:04 | $25.73 | 4,012 | $$103K | SELL |
5 dark pool trades shown · $$574K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for TNGX
PREVIEWSEPT Investing provides real-time options flow tracking for TNGX, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $19 | Jan 15 | 65 | $$4380 | 6 | SWEEP |
| CALL | $19 | Jan 15 | 65 | $$1520 | 2 | SWEEP |
| CALL | $19 | Jan 15 | 65 | $$1520 | 2 | SWEEP |
| CALL | $19 | Jan 15 | 65 | $$1520 | 2 | SWEEP |
| CALL | $19 | Jan 15 | 65 | $$1520 | 2 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About TNGX
2 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for TNGX. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Zone Setup -- $TNGX (Tango Therapeutics, Inc.) Price: $29.46 | Zone: $27.65 to $32.70 Conviction: HIGH | Analyst upside: +37.8% Near resistance (36% of range) — breakout watch. Strong positive news ...
Zone Setup -- $TNGX (Tango Therapeutics, Inc.) Price: $32.29 | Zone: $26.08 to $32.67 Conviction: HIGH | Analyst upside: +-6.7% Near resistance (94% of range) — breakout watch. Strong positive news ...
Join 3,500+ traders discussing TNGX in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Tango Therapeutics, Inc. (TNGX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →TNGX — frequently asked questions
What is TNGX stock price today?
Tango Therapeutics, Inc. (TNGX) is at $25.73, up 5.88% (+$1.43) at the Nov 11, 2026 close.
Why is TNGX stock up today?
Nov 10, 2026: Tango Therapeutics shares rose 6.86% today, closing at $24.30 on volume of over 4 million shares. The move followed analyst activity, with JP Morgan reiterating an Overweight rating and raising its price target to $47, while Wedbush maintained an Outperform rating but cut its target to $40.
What is the TNGX price target?
The average analyst price target for TNGX is $43.00, ranging from $24 to $68, based on 12 analysts. Latest: HC Wainwright & Co. maintains on Nov 10, 2026.
What do analysts rate TNGX?
Analyst ratings for TNGX: 1 Buy, 13 Hold, 3 Sell — consensus Hold.
Did TNGX beat earnings?
TNGX last reported on Nov 10, 2026: EPS -$0.39 vs -$0.35 expected — a miss of 10.5%.
Does TNGX pay a dividend?
TNGX does not currently pay a dividend.
What are TNGX support and resistance levels?
Support: $24.75, $20.74, $16.00. Resistance: $27.98, $30.25, $32.17.
What are insiders doing with TNGX?
Insider activity: SELLING, 0 buys and 11 sells in the last 90 days.
What is the latest news on TNGX?
Nov 10, 2026: Analysts adjust their views on Tango Therapeutics · Nov 10, 2026: JP Morgan keeps Overweight on Tango Therapeutics, lifts target to $47 · Nov 10, 2026: Wedbush keeps Outperform rating on Tango Therapeutics, cuts price target to $40